ELUT Q1 2023 Earnings — Elutia Inc. Revenue & Financial Results | Market Cap Arena

ELUTElutia Inc.

$48M

Q1 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$6M-44.4% YoY

Gross Profit

$3M52.8% margin

Operating Income

-$8M-130.5% margin

Net Income

-$8M-124.7% margin

EPS (Diluted)

$-0.49

QoQ Revenue Growth

-49.5%

Cash Flow

Operating Cash Flow

-$5M

Free Cash Flow

-$5M

Stock-Based Comp.

$684,000

Balance Sheet

Total Assets

$61M

Total Liabilities

$73M

Stockholders' Equity

-$12M

Cash & Equivalents

$12M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$6M	$11M	-44.4%
Gross Profit	$3M	$4M	-21.2%
Operating Income	-$8M	-$7M	-20.5%
Net Income	-$8M	-$8M	+2.1%